[HTML][HTML] From acute SARS-CoV-2 infection to pulmonary hypertension
E Eroume À Egom, HA Shiwani, B Nouthe - Frontiers in Physiology, 2022 - frontiersin.org
As the world progressively recovers from the acute stages of the coronavirus disease 2019
(COVID-19) pandemic, we may be facing new challenges regarding the long-term …
(COVID-19) pandemic, we may be facing new challenges regarding the long-term …
The effect of nirmatrelvir‐ritonavir on the long‐term risk of neuropsychiatric sequelae following COVID‐19
The retrospective cohort was conducted to assess the effect of nirmatrelvir‐ritonavir (NMV‐r)
on the long‐term risk of neuropsychiatric sequela following COVID‐19. TriNetX research …
on the long‐term risk of neuropsychiatric sequela following COVID‐19. TriNetX research …
[HTML][HTML] Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
W Wang, ND Volkow, NA Berger, PB Davis… - Nature …, 2024 - nature.com
Alcohol use disorders are among the top causes of the global burden of disease, yet
therapeutic interventions are limited. Reduced desire to drink in patients treated with …
therapeutic interventions are limited. Reduced desire to drink in patients treated with …
[HTML][HTML] A cross-sectional study of factors associated with COVID-19 testing among people who inject drugs: missed opportunities for reaching those most at risk
S Yeager, D Abramovitz, AY Harvey-Vera, CF Vera… - BMC Public Health, 2022 - Springer
Background People who inject drugs (PWID) are vulnerable to SARS-CoV-2 infection. We
examined correlates of COVID-19 testing among PWID in the US-Mexico border region and …
examined correlates of COVID-19 testing among PWID in the US-Mexico border region and …
Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits–United States, April 2020–December 2020
Introduction Sociodemographic factors and chronic conditions associated with coronavirus
disease 2019 (COVID-19) among persons with substance use disorder (PWSUD) are not …
disease 2019 (COVID-19) among persons with substance use disorder (PWSUD) are not …
COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
JJ Tsai, LT Liu, CH Chen, LJ Chen, SI Wang… - RMD open, 2023 - rmdopen.bmj.com
Objectives We aimed to investigate the role of rheumatoid arthritis (RA) with biologic or
targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) exposure in COVID …
targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) exposure in COVID …
COVID‐19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems
N Krawczyk, BD Rivera, C Basaraba, T Corbeil… - …, 2023 - Wiley Online Library
Abstract Background and Aims Individuals with opioid use disorder (OUD) suffer
disproportionately from COVID‐19. To inform clinical management of OUD patients …
disproportionately from COVID‐19. To inform clinical management of OUD patients …
[HTML][HTML] Disrupted seasonality and association of COVID-19 with medically attended respiratory syncytial virus infections among young children in the US: January …
Respiratory syncytial virus (RSV) infections and hospitalizations surged sharply in 2022
among young children. To assess whether COVID-19 contributed to this surge, we …
among young children. To assess whether COVID-19 contributed to this surge, we …
[HTML][HTML] COVID-19 vaccination and alcohol consumption: Justification of risks
PA Solopov - Pathogens, 2023 - mdpi.com
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic, pharmaceutical companies and research institutions have been actively working …
pandemic, pharmaceutical companies and research institutions have been actively working …
[HTML][HTML] Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel
Patients with schizophrenia show a substantial reduction in risk of COVID-19 severe illness
and related mortality when vaccinated, as compared to non-vaccinated samples1. However …
and related mortality when vaccinated, as compared to non-vaccinated samples1. However …